SY-008

N/A

Report date: 2026/02/05 09:12:24
NMEFirst In Class

Base Information

Drug NameSY-008
Drug Alias NameSY-008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/glucose cotransporter 1 inhibitors
TargetsSodium/glucose cotransporter 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesEli Lilly And CompanySuzhou Yabao Pharmaceutical R&D Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesYabao Pharmaceutical Group Co LtdSuzhou Yabao Pharmaceutical R&D Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A